Dynavax Technologies Corp (NASDAQ:DVAX)

21.98
Delayed Data
As of May 21
 +0.59 / +2.76%
Today’s Change
13.05
Today|||52-Week Range
26.89
+30.37%
Year-to-Date

Today’s Trading

Previous close21.39
Today’s open21.27
Day’s range20.76 - 22.24
Volume1,011,449
Average volume (3 months)432,789
Market cap$626.8M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-10.69%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book5.60

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...-0.05-0.61%
OREXOrexigen Therapeutic...-0.03-0.60%
INFIInfinity Pharmaceuti...+0.02+0.16%
CORTCorcept Therapeutics...+0.02+0.34%
Data as of 05/21/2015

Financials

Last reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.97
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers